Publication in The Journal of Molecular Diagnostics

An abstract that is received by the submission deadline will be considered for publication as an online supplement to the June 2024 issue of AMP’s official journal, The Journal of Molecular Diagnostics (JMD). In order to be eligible for publication in the JMD, this abstract must not have been published elsewhere and may not be currently under consideration as an abstract for another meeting that occurs prior to June 2024. You may, however, submit here if there are significant and substantive new data/findings in this submission. Additionally, if you submitted and/or presented an abstract at the 2023 AMP Annual Meeting, or plan to submit this abstract for the 2024 AMP Annual Meeting, this restriction is waived, but you are encouraged to include additional data if available. Acceptance for publication is the sole decision of the AMP Europe 2024 Organizing Committee.

Abstract Topics

• Genetics/Inherited Conditions
• Hematopathology
• Infectious Diseases
• Informatics
• Solid Tumors
• Other (Education, Quality/Process Improvement, Tech Topics, etc.)

*Abstract submissions in the “Other (Quality/Process Improvement, Education, Tech Topics, etc.)” topic category may include descriptions of novel educational approaches, innovative programs, pioneering technologies, etc. As with other abstract submissions, these abstract submissions must demonstrate the scientific method, i.e., describe the methodology and data collection, identify how to measure, analyze, and report outcomes, and provide conclusions.

Awards

2024 International Membership Grant

Laboratory scientists who reside in countries outside of the United States and who are currently involved in clinical molecular diagnostics are encouraged to apply. Successful applicants will receive AMP membership, active for one calendar year. Current or past AMP members are not eligible for this grant.

APPLY HERE

Submission Guidelines

Abstract Content

Please type your Abstract Title in title case, e.g., “This Is an Example of Title Case”. You may include italics (gene names), Greek letters, and special symbols, e.g. °C (degree sign), etc. The Abstract Title is limited to no more than 200 characters.
All abstracts are limited to a total of 3,000 characters (including spaces) and either one table or one chart.

Your abstract must include the following information:

1. Introduction: a brief discussion of the background or rationale of the study and/or the question addressed.
2. Methods: the experimental approach, materials, and methods used in the study.
3. Results: the data and results obtained in the study.
4. Conclusions: the conclusions and/or implications of the results.

Format Requirements

The five most common reasons for rejection are:

• Previously presented/published
• Poor organization/clarity
• Does not provide novel information
• Insufficient scientific quality
• Insufficient data

Abstracts that are not submitted properly will receive an administrative reject and will not be reviewed.

Abstract submission deadline: February 15, 2024

1. Abstracts must be submitted properly and in English. The online system is a database, with data fields (title, author 1, author 2, author 3, etc.) that are used to generate the published abstracts. Therefore, pay careful attention to the submission instructions and to the submission process, including spelling, capitalization, author names, etc. Avoid citing sources in your abstract. The abstract should focus on your original research, not on the work of others. The abstract should be self-contained and fully understandable without reference to other sources.
2. All abstracts must include the required headers listed below; each header must be included in your text:
   • Introduction
   • Methods
   • Results
   • Conclusions
3. Abstract Limits:
   • Number of authors: 30
   • Abstract Title: 200 characters
   • Abstract Content: 3000 characters (with spaces and including section headers)
4. You may include formatting (italicizing genes), Greek letters and special symbols, e.g., °C (degree sign), superscripts, etc. Data must be reported in narrative format in the abstract submission; tables and figured are not permitted.
5. Your abstract will be rated using four criteria:
   • Originality and Clarity
   • Novelty
   • Scientific Merit/Rigor
   • Appropriate Conclusions
6. Summary: Grounds for abstract rejection are:

• Abstracts that are not eligible for publication in JMD, i.e., have been submitted to another publication or to another meeting that occurs prior to June 2024. Exception: if you submitted and/or presented an abstract at an AMP Annual Meeting, this restriction is waived, but you are encouraged to include additional data if available. This waiver also applies when submitting to the AMP Annual Meeting & Expo events.

Message from the Congress Chair